Meeting Report: Hazard Assessment for Nanoparticles—Report from an Interdisciplinary Workshop
2007

Hazard Assessment for Nanoparticles

Sample size: 26 publication Evidence: moderate

Author Information

Author(s): John M. Balbus, Andrew D. Maynard, Vicki L. Colvin, Vincent Castranova, George P. Daston, Richard A. Denison, Kevin L. Dreher, Peter L. Goering, Alan M. Goldberg, Kristen M. Kulinowski, Nancy A. Monteiro-Riviere, Günter Oberdörster, Gilbert S. Omenn, Kent E. Pinkerton, Kenneth S. Ramos, Kathleen M. Rest, Jennifer B. Sass, Ellen K. Silbergeld, Brian A. Wong

Primary Institution: Woodrow Wilson International Center for Scholars

Hypothesis

What information is needed to understand the human health impact of engineered nanoparticles and how is this information best obtained?

Conclusion

The workshop concluded that a battery of tests should be developed to uncover particularly hazardous properties of nanoparticles.

Supporting Evidence

  • Participants noted the need for a standard set of nanoparticles to be validated for benchmarking tests.
  • Most participants agreed that existing in vivo toxicologic tests should be used to assess hazards of nanoparticles.
  • The workshop identified critical information needs for nanoparticle toxicity, including physicochemical characterization and potential for unintended carriage of toxic molecules.
  • Participants emphasized the importance of cross-disciplinary communication among researchers to better understand nanoparticle toxicity.
  • The group recommended developing a tiered testing approach for assessing nanoparticle hazards.

Takeaway

Scientists are trying to figure out how tiny particles called nanoparticles can affect our health and what tests we need to do to find out more.

Methodology

The workshop included plenary and multidisciplinary breakout sessions to discuss critical information needs and strategies for assessing nanoparticle toxicity.

Potential Biases

Some authors are affiliated with organizations that may have interests in nanotechnology regulation.

Limitations

The workshop's scope was limited to toxic properties of nanoparticles and did not fully evaluate human health risks.

Participant Demographics

Participants included scientists from government, academia, industry, and nonprofit organizations.

Digital Object Identifier (DOI)

10.1289/ehp.10327

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication